Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma

被引：217
作者：
Oberoi, Rajneet K. [1 ]
Parrish, Karen E. [1 ]
Sio, Terence T. [2 ]
Mittapalli, Rajendar K. [1 ]
Elmquist, William F. [1 ]
Sarkaria, Jann N. [2 ]
机构：
[1] Univ Minnesota, Coll Pharm, Dept Pharmaceut, Minneapolis, MN USA
[2] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA
来源：
NEURO-ONCOLOGY | 2016年 / 18卷 / 01期
关键词：
blood-brain barrier; drug delivery; efflux transporters; glioma; CANCER RESISTANCE PROTEIN; P-GLYCOPROTEIN ABCB1; SOLID LIPID NANOPARTICLES; CENTRAL-NERVOUS-SYSTEM; FOCUSED-ULTRASOUND; PHASE-I; TARGETED THERAPY; MEDIATED EFFLUX; DISRUPTION; GLIOMA;
D O I：
10.1093/neuonc/nov164
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Glioblastoma (GBM) is a lethal and aggressive brain tumor that is resistant to conventional radiation and cytotoxic chemotherapies. Molecularly targeted agents hold great promise in treating these genetically heterogeneous tumors, yet have produced disappointing results. One reason for the clinical failure of these novel therapies can be the inability of the drugs to achieve effective concentrations in the invasive regions beyond the bulk tumor. In this review, we describe the influence of the blood-brain barrier on the distribution of anticancer drugs to both the tumor core and infiltrative regions of GBM. We further describe potential strategies to overcome these drug delivery limitations. Understanding the key factors that limit drug delivery into brain tumors will guide future development of approaches for enhanced delivery of effective drugs to GBM.
引用
收藏
页码：27 / 36
页数：10
相关论文
共 85 条
  • [61] Differential Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on Axitinib Brain Accumulation and Oral Plasma Pharmacokinetics
    Poller, Birk
    Iusuf, Dilek
    Sparidans, Rolf W.
    Wagenaar, Els
    Beijnen, Jos H.
    Schinkel, Alfred H.
    [J]. DRUG METABOLISM AND DISPOSITION, 2011, 39 (05) : 729 - 735
  • [62] An Unexpected Synergist Role of P-Glycoprotein and Breast Cancer Resistance Protein on the Central Nervous System Penetration of the Tyrosine Kinase Inhibitor Lapatinib (N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine; GW572016)
    Polli, Joseph W.
    Olson, Katie L.
    Chism, John P.
    John-Williams, Lisa St.
    Yeager, Russell L.
    Woodard, Sesha M.
    Otto, Vicky
    Castellino, Stephen
    Demby, Victoria E.
    [J]. DRUG METABOLISM AND DISPOSITION, 2009, 37 (02) : 439 - 442
  • [63] Prados MD, 2003, NEURO-ONCOLOGY, V5, P96, DOI 10.1093/neuonc/5.2.96
  • [64] EFFECT OF CONCENTRATED SOLUTIONS ON BLOOD-BRAIN BARRIER
    RAPOPORT, SI
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1970, 219 (01): : 270 - &
  • [65] TESTING OF A HYPOTHESIS FOR OSMOTIC OPENING OF BLOOD-BRAIN BARRIER
    RAPOPORT, SI
    HORI, M
    KLATZO, I
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1972, 223 (02): : 323 - +
  • [66] New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy
    Rousselle, C
    Clair, P
    Lefauconnier, JM
    Kaczorek, M
    Scherrmann, JM
    Temsamani, J
    [J]. MOLECULAR PHARMACOLOGY, 2000, 57 (04) : 679 - 686
  • [67] Preclinical Assessment of the Absorption and Disposition of the Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor GDC-0980 and Prediction of Its Pharmacokinetics and Efficacy in Human
    Salphati, Laurent
    Pang, Jodie
    Plise, Emile G.
    Lee, Leslie B.
    Olivero, Alan G.
    Prior, Wei Wei
    Sampath, Deepak
    Wong, Susan
    Zhang, Xiaolin
    [J]. DRUG METABOLISM AND DISPOSITION, 2012, 40 (09) : 1785 - 1796
  • [68] Role of P-Glycoprotein and Breast Cancer Resistance Protein-1 in the Brain Penetration and Brain Pharmacodynamic Activity of the Novel Phosphatidylinositol 3-Kinase Inhibitor GDC-0941
    Salphati, Laurent
    Lee, Leslie B.
    Pang, Jodie
    Plise, Emile G.
    Zhang, Xiaolin
    [J]. DRUG METABOLISM AND DISPOSITION, 2010, 38 (09) : 1422 - 1426
  • [69] Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography
    Sasongko, L
    Link, JM
    Muzi, M
    Mankoff, DA
    Yang, XD
    Collier, AC
    Shoner, SC
    Unadkat, JD
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (06) : 503 - 514
  • [70] Drug delivery to brain via the blood-brain barrier
    Scherrmann, JM
    [J]. VASCULAR PHARMACOLOGY, 2002, 38 (06) : 349 - 354
123456789